Anti-Aβ agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis | Journal of Neurology, Neurosurgery & Psychiatry

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

JNNP 100

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Neurodegeneration

Original research

Anti-Aβ agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis

Online download statistics by month:

Online download statistics by month: October 2020 to March 2024

	Abstract	Full	Pdf
Oct 2020	1765	61	35
Nov 2020	660	59	37
Dec 2020	467	54	31
Jan 2021	247	28	21
Feb 2021	270	12	25
Mar 2021	266	26	22
Apr 2021	288	32	28
May 2021	141	40	27
Jun 2021	18	16	11
Jul 2021	35	32	8
Aug 2021	21	18	6
Sep 2021	29	25	5
Oct 2021	256	23	4
Nov 2021	259	27	15
Dec 2021	434	38	22
Jan 2022	225	14	6
Feb 2022	180	18	8
Mar 2022	293	31	5
Apr 2022	254	30	7
May 2022	337	47	2
Jun 2022	226	19	6
Jul 2022	261	24	1
Aug 2022	181	13	1
Sep 2022	153	13	5
Oct 2022	235	20	10
Nov 2022	202	29	4
Dec 2022	157	8	3
Jan 2023	194	23	10
Feb 2023	208	10	1
Mar 2023	193	24	4
Apr 2023	179	18	8
May 2023	159	16	5
Jun 2023	123	12	3
Jul 2023	174	9	0
Aug 2023	200	7	3
Sep 2023	130	8	4
Oct 2023	126	12	2
Nov 2023	210	18	11
Dec 2023	269	12	15
Jan 2024	280	20	20
Feb 2024	194	11	10
Mar 2024	194	17	8
Total	10693	974	459